94 related articles for article (PubMed ID: 15064752)
61. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis.
Hsu TC; Young MR; Cmarik J; Colburn NH
Free Radic Biol Med; 2000 May; 28(9):1338-48. PubMed ID: 10924853
[TBL] [Abstract][Full Text] [Related]
62. Gene regulation and genetic susceptibility to neoplastic transformation: AP-1 and p80 expression in JB6 cells.
Bernstein LR; Ben-Ari ET; Simek SL; Colburn NH
Environ Health Perspect; 1991 Jun; 93():111-9. PubMed ID: 1773784
[TBL] [Abstract][Full Text] [Related]
63. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets.
Kundu JK; Shin YK; Surh YJ
Biochem Pharmacol; 2006 Nov; 72(11):1506-15. PubMed ID: 16999939
[TBL] [Abstract][Full Text] [Related]
64. The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive.
Dhar A; Young MR; Colburn NH
Mol Cell Biochem; 2002; 234-235(1-2):185-93. PubMed ID: 12162432
[TBL] [Abstract][Full Text] [Related]
65. Glucocorticoid mediation of dietary energy restriction inhibition of mouse skin carcinogenesis.
Birt DF; Yaktine A; Duysen E
J Nutr; 1999 Feb; 129(2S Suppl):571S-574S. PubMed ID: 10064335
[TBL] [Abstract][Full Text] [Related]
66. Molecular targets of the oncogenic transcription factor jun.
Hartl M; Bader AG; Bister K
Curr Cancer Drug Targets; 2003 Feb; 3(1):41-55. PubMed ID: 12570660
[TBL] [Abstract][Full Text] [Related]
67. The high mobility group A1 molecular switch: turning on cancer - can we turn it off?
Huso TH; Resar LM
Expert Opin Ther Targets; 2014 May; 18(5):541-53. PubMed ID: 24684280
[TBL] [Abstract][Full Text] [Related]
68. Effects of food factors on signal transduction pathways.
Dong Z
Biofactors; 2000; 12(1-4):17-28. PubMed ID: 11216482
[TBL] [Abstract][Full Text] [Related]
69. The HMGA proteins: a myriad of functions (Review).
Cleynen I; Van de Ven WJ
Int J Oncol; 2008 Feb; 32(2):289-305. PubMed ID: 18202751
[TBL] [Abstract][Full Text] [Related]
70. The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.
Sumter TF; Xian L; Huso T; Koo M; Chang YT; Almasri TN; Chia L; Inglis C; Reid D; Resar LM
Curr Mol Med; 2016; 16(4):353-93. PubMed ID: 26980699
[TBL] [Abstract][Full Text] [Related]
71. High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential.
Wang L; Zhang J; Xia M; Liu C; Zu X; Zhong J
Int J Biol Sci; 2022; 18(11):4414-4431. PubMed ID: 35864955
[TBL] [Abstract][Full Text] [Related]
72. The high mobility group A1 gene: transforming inflammatory signals into cancer?
Resar LM
Cancer Res; 2010 Jan; 70(2):436-9. PubMed ID: 20068164
[TBL] [Abstract][Full Text] [Related]
73. HMGA molecules in neuroblastic tumors.
Cerignoli F; Ambrosi C; Mellone M; Assimi I; di Marcotullio L; Gulino A; Giannini G
Ann N Y Acad Sci; 2004 Dec; 1028():122-32. PubMed ID: 15650238
[TBL] [Abstract][Full Text] [Related]
74. Molecular mechanism of HMGA1 deregulation in human neuroblastoma.
Giannini G; Cerignoli F; Mellone M; Massimi I; Ambrosi C; Rinaldi C; Gulino A
Cancer Lett; 2005 Oct; 228(1-2):97-104. PubMed ID: 15923078
[TBL] [Abstract][Full Text] [Related]
75. The role of high mobility group AT-hook 1 in viral infections: Implications for cancer pathogenesis.
Akade E; Jalilian S
Int J Biochem Cell Biol; 2024 Apr; 169():106532. PubMed ID: 38278412
[TBL] [Abstract][Full Text] [Related]
76. High mobility group A1 and cancer: potential biomarker and therapeutic target.
Shah SN; Resar LM
Histol Histopathol; 2012 May; 27(5):567-79. PubMed ID: 22419021
[TBL] [Abstract][Full Text] [Related]
77. HMGA1-pseudogenes and cancer.
De Martino M; Forzati F; Arra C; Fusco A; Esposito F
Oncotarget; 2016 May; 7(19):28724-35. PubMed ID: 26895108
[TBL] [Abstract][Full Text] [Related]
78. Charles S. Mott Prize. Jun: a transcription factor becomes oncogenic.
Vogt PK
Cancer; 1992 May; 69(10):2610-4. PubMed ID: 1568185
[No Abstract] [Full Text] [Related]
79. HMGA1 in cancer: Cancer classification by location.
Wang Y; Hu L; Zheng Y; Guo L
J Cell Mol Med; 2019 Apr; 23(4):2293-2302. PubMed ID: 30614613
[TBL] [Abstract][Full Text] [Related]
80. Lessons from the Crypt: HMGA1-Amping up Wnt for Stem Cells and Tumor Progression.
Resar L; Chia L; Xian L
Cancer Res; 2018 Apr; 78(8):1890-1897. PubMed ID: 29618461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
